CN Patent

CN101137631A — 杂芳族葡糖激酶激活剂

Assigned to vTv Therapeutics LLC · Expires 2008-03-05 · 18y expired

What this patent protects

本发明描述了式(I)的2，3－二取代的N－杂芳族丙酰胺类，其中在3－位的取代是任选取代的苯基环，并且在2－位的取代是烷基或者环烷基；包含它的药物组合物；及其使用方法。所述丙酰胺类是用于治疗II型糖尿病的葡糖激酶激活剂。

USPTO Abstract

本发明描述了式(I)的2，3－二取代的N－杂芳族丙酰胺类，其中在3－位的取代是任选取代的苯基环，并且在2－位的取代是烷基或者环烷基；包含它的药物组合物；及其使用方法。所述丙酰胺类是用于治疗II型糖尿病的葡糖激酶激活剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN101137631A
Jurisdiction
CN
Classification
—
Expires
2008-03-05
Drug substance claim
No
Drug product claim
No
Assignee
vTv Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.